Sonoma Pharmaceuticals (SNOA) Share-based Compensation Growth (3y) (2013 - 2026)
Sonoma Pharmaceuticals (SNOA) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 10.06% |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 9.14% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.43% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -8.13% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -1.73% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | -8.04% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.12 Mn | -222,819.83 | 2.58 Mn | -31.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -31.06% |
| Mar 31, 2026 | 10.52% |
| Dec 31, 2025 | -20.63% |
| Sep 30, 2025 | -28.79% |
| Jun 30, 2025 | -35.66% |
| Mar 31, 2025 | -23.62% |
| Dec 31, 2024 | -38.54% |
| Sep 30, 2024 | 67.11% |
| Jun 30, 2024 | 24.09% |
| Mar 31, 2024 | 7.85% |
| Dec 31, 2023 | 14.61% |
| Sep 30, 2023 | -6.69% |
| Jun 30, 2023 | 41.11% |
| Mar 31, 2023 | -30.82% |
| Dec 31, 2022 | 29.28% |
| Sep 30, 2022 | 128.94% |
| Jun 30, 2022 | 120.36% |
| Mar 31, 2022 | 19.97% |
| Dec 31, 2021 | -48.16% |
| Sep 30, 2021 | -82.13% |